Sapphiros

Boston, United States

Sapphiros invests in growth-stage diagnostic companies, focusing on technologies that prioritize innovation and patient-centric approaches.

$30.0M raised

Jan 2024

Series B

Top Investors

National Institutes of HealthKohlberg Kravis RobertsOraSure Technologies

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Sapphiros raised?

Sapphiros has raised $30.0M in total funding. The most recent round was Series B. The last funding was announced in January 2024.

Who are Sapphiros's investors?

Sapphiros's investors include National Institutes of Health, Kohlberg Kravis Roberts, OraSure Technologies.

Where is Sapphiros headquartered?

Sapphiros is headquartered in Boston, United States.

What does Sapphiros do?

Sapphiros invests in growth-stage diagnostic companies, focusing on technologies that prioritize innovation and patient-centric approaches.

What stage is Sapphiros at?

Sapphiros is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 4, 2024.

MLA

"Sapphiros — Funding & Investors." VCBacked, January 4, 2024, https://www.vcbacked.co/company/sapphiros. Accessed June 4, 2026.

APA

VCBacked. (2024). Sapphiros — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/sapphiros

Wikipedia (cite web)

{{cite web |title=Sapphiros — Funding & Investors |url=https://www.vcbacked.co/company/sapphiros |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 4, 2024.